Showing 1 - 20 results of 1,788 for search '(( significant largest decrease ) OR ( significant reduction tailored ))', query time: 0.48s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? by Matilde Corianò (14707868)

    Published 2023
    “…We observed a statistically significant longer PFS and OS in patients who underwent dose reductions (<i>p</i> < 0.0001 for both PFS and OS), temporary interruption (<i>p</i> < 0.0001 for both PFS and OS) and schedule modifications (<i>p</i> = 0.007 for PFS and <i>p</i> = 0.012 for OS) at univariate analysis. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20